A compound with the SMILES Cc1c(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CCCC(O)C4)c(F)c32)c(=O)n(-c2ccccc2)n1C has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 6.460\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1c(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CCCC(O)C4)c(F)c32)c(=O)n(-c2ccccc2)n1C
Cc1c(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CCCC(O)C4)c(F)c32)c(=O)n(-c2ccccc2)n1C
1-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-6,8-difluoro-7-(3-hydroxypiperidin-1-yl)-4-oxoquinoline-3-carboxylic acid